We are live on ! Find out more
UTHR icon

United Therapeutics

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2%99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 2418 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M
Name Holding Trade Value Shares
Change
Change in
Stake
PWMG
451
Prestige Wealth Management Group
New Jersey
$1K
TFA
452
Transamerica Financial Advisors
Florida
$1K
VCM
453
Versant Capital Management
Arizona
$1K
AF
454
Allworth Financial
California
$1K +$894 +4 +400%
EWA
455
EverSource Wealth Advisors
Alabama
$1K +$894 +4 New
SPIA
456
Steward Partners Investment Advisory
New York
$1K +$894 +4 New
LFA
457
Legend Financial Advisors
Pennsylvania
$838 +$894 +4 New
SWA
458
Sutton Wealth Advisors
Florida
$628
FSWA
459
Financial Synergies Wealth Advisors
Texas
$210
FAM
460
Fred Alger Management
New York
-$19.5M -82,844 Closed
IC
461
Ikarian Capital
Texas
-$9.43M -40,000 Closed
CF
462
Cantor Fitzgerald
New York
-$8.13M -34,490 Closed
TA
463
Tamarack Advisers
California
-$7.07M -30,000 Closed
State of Tennessee, Department of Treasury
464
State of Tennessee, Department of Treasury
Tennessee
-$6.28M -26,664 Closed
BNP Paribas Asset Management
465
BNP Paribas Asset Management
France
-$6.08M -25,800 Closed
CM
466
Castleark Management
Illinois
-$5.97M -25,350 Closed
JGC
467
J. Goldman & Co
New York
-$5.8M -24,622 Closed
Point72 Asset Management
468
Point72 Asset Management
Connecticut
-$4.67M -19,815 Closed
EF
469
Empowered Funds
Pennsylvania
-$4.34M -18,439 Closed
Capital Fund Management (CFM)
470
Capital Fund Management (CFM)
France
-$3.03M -12,857 Closed
EGI
471
EAM Global Investors
California
-$2.61M -11,092 Closed
Squarepoint
472
Squarepoint
New York
-$2.37M -10,600 Closed
BCM
473
Bayesian Capital Management
New York
-$2.24M -9,500 Closed
SG Americas Securities
474
SG Americas Securities
New York
-$2.13M -9,030 Closed
ERSOT
475
Employees Retirement System of Texas
Texas
-$1.89M -8,000 Closed

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.